BHCM
TDOC icon

Brevan Howard Capital Management’s Teladoc Health TDOC Stock Holding History

Brevan Howard Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Sell
221,708
-22,271
-9% -$148K 0.01% 747
2026
Q1 		$1.33M Buy
243,979
+161,417
+196% +$906K 0.01% 758
2025
Q4 		$578K Sell
82,562
-31,694
-28% -$248K 0.01% 1029
2025
Q3 		$883K Sell
114,256
-218,043
-66% -$1.7M ﹤0.01% 962
2025
Q2 		$2.89M Buy
332,299
+312,038
+1,540% +$2.26M 0.02% 591
2025
Q1 		$161K Sell
20,261
-208,090
-91% -$2.11M ﹤0.01% 1013
2024
Q4 		$2.08M Buy
228,351
+75,961
+50% +$733K 0.01% 277
2024
Q3 		$1.4M Buy
152,390
+140,803
+1,215% +$1.17M 0.01% 348
2024
Q2 		$113K Sell
11,587
-17,168
-60% -$209K ﹤0.01% 960
2024
Q1 		$434K Buy
+28,755
New +$522K ﹤0.01% 504

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Brevan Howard Capital Management's TDOC Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Teladoc Health (TDOC) stake by 9.1% in Q2 2026, selling an estimated $148K and leaving 221,708 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #747.

Brevan Howard Capital Management first reported a position in TDOC in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.89M in Q2 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Brevan Howard Capital Management held 221,708 shares of Teladoc Health worth $1.88M as of Q2 2026.
  • Brevan Howard Capital Management sold 22,271 Teladoc Health shares in Q2 2026, an estimated $148K.
  • Teladoc Health made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #747 holding.
  • Brevan Howard Capital Management first reported a position in Teladoc Health in Q1 2024 and has held it in 10 quarters since.
  • Brevan Howard Capital Management's Teladoc Health position peaked at $2.89M in Q2 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.